Phosphatidyl choline-based colloidal systems for dermal and transdermal drug delivery

References

• Alany RG, Tucker IG, Davies NM, Rades T. (2001). Characterizing colloidal structures of pseudoternary phase diagrams formed by oil/water/amphiphile systems. Drug Dev Ind Pharm 27:31–38.
   PubMed Web of Science ®Google Scholar
• Avdeef A, Box KJ, Comer JEA, Hibbert C, Tam KY. (1998). pH-Metric logP 10. Determination of liposomal membrane-water partition coefficients of lonizable drugs. Pharm Res 15:209–215.
   PubMed Web of Science ®Google Scholar
• Barry BW. (1991). Modern methods of promoting drug absorption through the skin. Mol Aspects Med 12:195–241.
   PubMed Web of Science ®Google Scholar
• Bouwstra JA, de Graaff A, Gooris GS, Nijsse J, Wiechers JW, van Aelst AC. (2003). Water distribution and related morphology in human stratum corneum at different hydration levels. J Invest Dermatol 120:750–758.
   PubMed Web of Science ®Google Scholar
• Bouwstra JA, Honeywell-Nguyen PL. (2002). Skin structure and mode of action of vesicles. Adv Drug Deliv Rev 54:S41–S55.
   PubMed Web of Science ®Google Scholar
• Bucks DAW, McMaster JR, Maibach HI, Guy RH. (1988). Bioavailability of topically administered steroids: a “mass balance” technique. J Invest Dermatol 91:29–33.
   PubMed Web of Science ®Google Scholar
• Cappel MJ, Kreuter J. (1991). Effect of nonionic surfactants on transdermal drug delivery: I. Polysorbates. Int J Pharm 69:143–153.
   Web of Science ®Google Scholar
• Cevc G. (2004). Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev 56:675–711.
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G. (1992). Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta 1104:226–232.
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G. (2004). Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage. Biochim Biophys Acta 1663:61–73.
   PubMed Web of Science ®Google Scholar
• Cevc G, Gebauer D. (2003). Hydration-driven transport of deformable lipid vesicles through fine pores and the skin barrier. Biophys J 84:1010–1024.
   PubMed Web of Science ®Google Scholar
• Cevc G, Gebauer D, Stieber J, Schatzlein A, Blume G. (1998). Ultraflexible vesicles, transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta 1368:201–215.
   PubMed Web of Science ®Google Scholar
• Cevc G, Mazgareanu S, Rother M, Vierl U. (2008). Occlusion effect on transcutaneous NSAID delivery from conventional and carrier-based formulations. Int J Pharm 359:190–197.
   PubMed Web of Science ®Google Scholar
• Cevc G, Schatzlein A, Richardsen H. (2002). Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. Biochim Biophys Acta 1564:21–30.
   PubMed Web of Science ®Google Scholar
• Cilurzo F, Minghetti P, Chiara S. (2007). Newborn pig skin as model membrane in in vitro drug permeation studies: A technical note. AAPS PharmSciTech 8:97–100.
   Web of Science ®Google Scholar
• Cross SE, Magnusson BM, Winckle G, Anissimov Y, Roberts MS. (2003). Determination of the effect of lipophilicity on the in vitro permeability and tissue reservoir characteristics of topically applied solutes in human skin layers. J Invest Dermatol 120:759–764.
   PubMed Web of Science ®Google Scholar
• Davis AF, Gyurik RJ, Hadgraft J, Walters KA. (2002). Formulation strategies for modulating skin permeation. In: Walters KA (Ed.), Dermatological and Transdermal Formulations ( pp 271–318). New York: Informa Health Care.
   Google Scholar
• Dreher F, Walde P, Walther P, Wehrli E. (1997). Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport. J Contr Rel 45:131–140.
   Web of Science ®Google Scholar
• El Maghraby GMM, Williams AC, Barry BW. (2000a). Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int J Pharm 196:63–74.
   PubMed Web of Science ®Google Scholar
• El Maghraby GMM, Williams AC, Barry BW. (2000b). Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. Int J Pharm 204:159–169.
   PubMed Web of Science ®Google Scholar
• El Maghraby GMM, Williams AC, Barry BW. (2006). Can drug-bearing liposomes penetrate intact skin? J Pharm Pharmacol 58:415–429.
   PubMed Web of Science ®Google Scholar
• Elias PM, Cooper ER, Korc A, Brown BE. (1981). Percutaneous transport in relation to stratum corneum structure and lipid composition. J Invest Dermatol 76:297–301.
   PubMed Web of Science ®Google Scholar
• Fang Y-P, Wu P-C, Tsai Y-H, Huang Y-B. (2008). Physicochemical and safety evaluation of 5-aminolevulinic acid in novel liposomes as carrier for skin delivery. J Liposome Res 18:31–45.
   PubMed Web of Science ®Google Scholar
• Gray GM, Yardley HJ. (1975). Lipid compositions of cells isolated from pig, human, and rat epidermis. J Lipid Res 16:434–440.
   PubMed Web of Science ®Google Scholar
• Green PG, Hadgraft J. (1987). Facilitated transfer of cationic drugs across a lipoidal membrane by oleic acid and lauric acid. Int J Pharm 37:251–255.
   Web of Science ®Google Scholar
• Hadgraft J. (2001). Skin, the final frontier. Int J Pharm 224:1–18.
   PubMed Web of Science ®Google Scholar
• Hadgraft J, Guy RH. (2003). Feasibility assessment in topical and transdermal delivery: mathematical models and in vitro studies. In: Guy RH, Hadgraft J (Eds.), Transdermal Drug Delivery ( pp 1–24). New York: Marcel Dekker.
   Google Scholar
• Herbette L, Katz AM, Sturtevant JM. (1983). Comparisons of the interaction of propranolol and timolol with model and biological membrane systems. Mol Pharmacol 24:259–269.
   PubMed Web of Science ®Google Scholar
• Junyaprasert VB, Boonme P, Songkro S, Krauel K, Rades T. (2007). Transdermal delivery of hydrophobic and hydrophilic local anesthetics from o/w and w/o Brij 97-based microemulsions. J Pharm Pharm Sci 10:288–298.
   PubMed Web of Science ®Google Scholar
• Kirjavainen M, Mönkkönen J, Saukkosaari M, Valjakka-Koskela R, Kiesvaara J, Urtti A. (1999a). Phospholipids affect stratum corneum lipid bilayer fluidity and drug partitioning into the bilayers. J Contr Rel 58:207–214.
   PubMed Web of Science ®Google Scholar
• Kirjavainen M, Urtti A, Jaaskelainen I, Suhonen TM, Paronen P, Valjakka-Koskela R, et al. (1996). Interaction of liposomes with human skin in vitro—the influence of lipid composition and structure. Biochim Biophys Acta 1304:179–189.
   PubMed Web of Science ®Google Scholar
• Kirjavainen M, Urtti A, Valjakka-Koskela R, Kiesvaara J, Monkkonen J. (1999b). Liposome-skin interactions and their effects on the skin permeation of drugs. Eur J Pharm Sci 7:279–286.
   PubMed Web of Science ®Google Scholar
• Kreilgaard M. (2002). Influence of microemulsions on cutaneous drug delivery. Adv Drug Deliv Rev 54:S77–S98.
   PubMed Web of Science ®Google Scholar
• Ktistis G, Niopas I. (1998). A study on the in-vitro percutaneous absorption of propranolol from disperse systems. J Pharm Pharmacol 50:413–418.
   PubMed Web of Science ®Google Scholar
• Lasch J, Zellmer S, Pfeil W, Schubert R. (1995). Interaction of liposomes with the human skin lipid barrier: hSclls as model system—DSC of intact stratum corneum and in situ CLSM of human skin. J Liposome Res 5:99–108.
   Google Scholar
• Lee EH, Kim A, Oh Y-K, Kim C-K. (2005). Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes. Biomaterials 26:205–210.
   PubMed Web of Science ®Google Scholar
• Lee PJ, Langer R, Shastri VP. (2003). Novel microemulsion enhancer formulation for simultaneous transdermal delivery of hydrophilic and hydrophobic drugs. Pharm Res 20:264–269.
   PubMed Web of Science ®Google Scholar
• Meyer W, Neurand K. (1991). Comparison of skin pH in domesticated and laboratory mammals. Arch Dermatol Res 283:16–18.
   PubMed Web of Science ®Google Scholar
• Mishra D, Garg M, Dubey V, Jain S, Jain NK. (2007). Elastic liposomes mediated transdermal delivery of an anti-hypertensive agent: propranolol hydrochloride. J Pharm Sci 96:145–155.
   PubMed Web of Science ®Google Scholar
• Paolino D, Ventura CA, Nistico S, Puglisi G, Fresta M. (2002). Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability. Int J Pharm 244:21–31.
   PubMed Web of Science ®Google Scholar
• Peltola S, Saarinen-Savolainen P, Kiesvaara J, Suhonen TM, Urtti A. (2003). Microemulsions for topical delivery of estradiol. Int J Pharm 254:99–107.
   PubMed Web of Science ®Google Scholar
• Šentjurc M, Vrhovnik K, Kristl J. (1999). Liposomes as a topical delivery system: the role of size on transport studied by the EPR imaging method. J Contr Rel 59:87–97.
   PubMed Web of Science ®Google Scholar
• Shah VP, Peck CC, Williams RL. (1993). Skin penetration enhancement: clinical pharmacological and regulatory consideration. In: Walters KA, Hadgraft J (Eds.), Pharmacetical Skin Penetration Enhancement ( pp 417–428). New York: Marcel Dekker.
   Google Scholar
• Sinico C, Caddeo C, Valenti D, Fadda AM, Bilia AR, Vincieri FF. (2008). Liposomes as carriers for verbascoside: stability and skin permeation studies. J Liposome Res 18:83–90.
   PubMed Web of Science ®Google Scholar
• Sinico C, Manconi M, Peppi M, Lai F, Valenti D, Fadda AM. (2005). Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction. J Contr Rel 103:123–136.
   PubMed Web of Science ®Google Scholar
• Songkro S, Purwo Y, Rades T, Becket G. (2003a). Investigation of newborn pig skin as an in vitro animal model for transdermal drug delivery. S T P Pharma Sci 13:133–139.
   Google Scholar
• Songkro S, Rades T, Becket G. (2003b). The effect of p-menthane monoterpenes and related compounds on the percutaneous absorption of propranolol hydrochloride across newborn pig skin I. In vitro skin permeation and retention studies. S T P Pharma Sci 13:349–357.
   Google Scholar
• Stott PW, Williams AC, Barry BW. (2001). Mechanistic study into the enhanced transdermal permeation of a model β-blocker, propranolol, by fatty acids: a melting point depression effect. Int J Pharm 219:161–176.
   PubMed Web of Science ®Google Scholar
• Trotta M, Peira E, Carlotti ME, Gallarate M. (2004). Deformable liposomes for dermal administration of methotrexate. Int J Pharm 270:119–125.
   PubMed Web of Science ®Google Scholar
• van den Bergh BAI, Wertz PW, Junginger HE, Bouwstra JA. (2001). Elasticity of vesicles assessed by electron spin resonance, electron microscopy, and extrusion measurements. Int J Pharm 217:13–24.
   PubMed Web of Science ®Google Scholar
• Williams AC, Barry BW. (2004). Penetration enhancers. Adv Drug Deliv Rev 56:603–618.
   PubMed Web of Science ®Google Scholar
• Zhai H, Maibach HI. (2001). Effects of skin occlusion on percutaneous absorption: an overview. Skin Pharmacol Physiol 14:1–10.
   Web of Science ®Google Scholar
• Zhao K, Singh J. (1999). In vitro percutaneous absorption enhancement of propranolol hydrochloride through porcine epidermis by terpenes/ethanol. J Contr Rel 62:359–366.
   PubMed Web of Science ®Google Scholar